TY - JOUR
T1 - Experimental therapeutics of Nrf2 as a target for prevention of bacterial exacerbations in COPD
AU - Biswal, Shyam
AU - Thimmulappa, Rajesh K.
AU - Harvey, Christopher J.
PY - 2012/5/1
Y1 - 2012/5/1
N2 - A growing body of evidence indicates that oxidative stress plays a central role in the progression of chronic obstructive pulmonary disease (COPD). Chronic oxidative stress caused by cigarette smoke generates damage-associated molecular patterns (DAMPs), such as oxidatively or nitrosatively modified proteins and extracellular matrix fragments, which induce abnormal airway inflammation by activating innate and adaptive immune responses. Furthermore, oxidative stress-induced histone deacetylase 2 (HDAC2) inactivity is implicated in amplifying inflammatory responses and corticosteroid resistance in COPD. Oxidative stress also mediates disruption of innate immune defenses, which is associated with acute exacerbation of COPD. Host defense transcription factor Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates a multifaceted cytoprotective response to counteract oxidative stress-induced pathological injuries. A decrease in Nrf2 signaling is associated with the progression of diseases. Recent evidence indicates that targeting Nrf2 can be a novel therapy to mitigate inflammation, improve innate antibacterial defenses, and restore corticosteroid responses in patients with COPD.
AB - A growing body of evidence indicates that oxidative stress plays a central role in the progression of chronic obstructive pulmonary disease (COPD). Chronic oxidative stress caused by cigarette smoke generates damage-associated molecular patterns (DAMPs), such as oxidatively or nitrosatively modified proteins and extracellular matrix fragments, which induce abnormal airway inflammation by activating innate and adaptive immune responses. Furthermore, oxidative stress-induced histone deacetylase 2 (HDAC2) inactivity is implicated in amplifying inflammatory responses and corticosteroid resistance in COPD. Oxidative stress also mediates disruption of innate immune defenses, which is associated with acute exacerbation of COPD. Host defense transcription factor Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates a multifaceted cytoprotective response to counteract oxidative stress-induced pathological injuries. A decrease in Nrf2 signaling is associated with the progression of diseases. Recent evidence indicates that targeting Nrf2 can be a novel therapy to mitigate inflammation, improve innate antibacterial defenses, and restore corticosteroid responses in patients with COPD.
KW - Bacteria
KW - COPD
KW - Exacerbation
KW - Nrf2
KW - Therapeutics
UR - http://www.scopus.com/inward/record.url?scp=84862613471&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862613471&partnerID=8YFLogxK
U2 - 10.1513/pats.201201-009MS
DO - 10.1513/pats.201201-009MS
M3 - Article
C2 - 22550241
AN - SCOPUS:84862613471
SN - 1546-3222
VL - 9
SP - 47
EP - 51
JO - Proceedings of the American Thoracic Society
JF - Proceedings of the American Thoracic Society
IS - 2
ER -